Concepedia

Michele Fusaroli

MF

Statistics

Publications

29

Citations

1.3K

H-Index

19

Active since

2020

Affiliations

University of Bologna(Current)

Azienda USL di Bologna

IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola

Inserm

University of Milan

Michele Fusaroli is an author at University of Bologna specializing in adverse drug event reporting, pharmacovigilance, and pharmacology.

ORCID

Publications per year

2020–2024

29

Publications

29

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

Michele Fusaroli, Francesco Salvo, Bernard Bégaud et al. · Drug Safety · 2024 · 273 citations · Full text

, , +15

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement

Michele Fusaroli, Francesco Salvo, Bernard Bégaud et al. · Drug Safety · 2024 · 183 citations · Full text

, , +16

Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment

Emanuel Raschi, Michele Fusaroli, Andrea Ardizzoni et al. · Breast Cancer Research and Treatment · 2020 · 106 citations · Full text

, , +14

Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database

Michele Fusaroli, Valentina Isgrò, Paola Maria Cutroneo et al. · Drug Safety · 2022 · 62 citations · Full text

, , +16

Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System

Emanuel Raschi, Michele Fusaroli, M. La Plaça et al. · American Journal of Clinical Dermatology · 2021 · 57 citations

, , +17

1–5 of 29